Provided by Tiger Trade Technology Pte. Ltd.

PolyPid Ltd.

4.28
-0.0400-0.93%
Post-market: 4.280.00000.00%16:10 EDT
Volume:51.33K
Turnover:223.93K
Market Cap:81.68M
PE:-2.05
High:4.47
Open:4.36
Low:4.25
Close:4.32
52wk High:5.12
52wk Low:2.30
Shares:19.08M
Float Shares:10.25M
Volume Ratio:1.07
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0900
EPS(LYR):-2.0900
ROE:-366.29%
ROA:-86.71%
PB:7.44
PE(LYR):-2.05

Loading ...

PolyPid files initial beneficial ownership statement; COO-US Ori Warshavsky reports 267 ordinary shares owned directly

Reuters
·
Yesterday

PolyPid files initial beneficial ownership statement; director Nir Dror-Darwish reports 14,440 stock options at $2.67

Reuters
·
Mar 26

PolyPid Ltd. CFO Jonathan Missulawin files initial beneficial ownership statement

Reuters
·
Mar 24

PolyPid Director Joseph BenAmram Files Initial Beneficial Ownership Statement

Reuters
·
Mar 23

PolyPid Director Brooke Story Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

PolyPid Files Form 3 Initial Beneficial Ownership Statement for Director Itzhak Krinsky

Reuters
·
Mar 19

PolyPid Deputy CEO Dalit Fellous Hazan Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Roth MKM Reaffirms Their Buy Rating on PolyPid (PYPD)

TIPRANKS
·
Mar 17

BRIEF-Polypid Receives PDUFA Fee Waiver From FDA For D-Plex₁₀₀’S New Drug Application

Reuters
·
Mar 17

PolyPid Receives Pdufa Fee Waiver From FDA for D-Plex₁₀₀’S New Drug Application

THOMSON REUTERS
·
Mar 17

PolyPid Ltd - on Track to Initiate Nda Submission for D-Plex₁₀₀ by End of March 2026

THOMSON REUTERS
·
Mar 17

PolyPid FY 2025 marketing and business development expense rises to USD 2.0 million (+109.2%)

Reuters
·
Feb 26

PolyPid Senior Management to Join Citizens 2026 Life Sciences Conference and 38th Annual ROTH Conference Fireside Chats

Reuters
·
Feb 25

PolyPid Announces Participation in Upcoming Investor Conferences

GlobeNewswire
·
Feb 25

Analysts Are Bullish on Top Healthcare Stocks: PolyPid (PYPD), Dexcom (DXCM)

TIPRANKS
·
Feb 13

PolyPid Earnings Call Flags Big 2026 Catalyst

TIPRANKS
·
Feb 12

PolyPid Price Target Maintained With a $13.00/Share by HC Wainwright & Co.

Dow Jones
·
Feb 12

PolyPid: Advancing D-PLEX100 De-Risks Platform Potential and Creates Compelling Buy-Rated Risk-Reward

TIPRANKS
·
Feb 12

Israel's PolyPid Q4 EPS improves on lower R&D expenses

Reuters
·
Feb 11

BRIEF-PolyPid Q4 Net Income USD -8.5 Million

Reuters
·
Feb 11